Posts by Brian Westerlind
President’s Outlook 2018
By Mark Land, AAHP President March 1, 2018 Our association concluded one of its most successful years in 2017. The momentum created last year is a catalyst for continued growth…
Read MoreThe German Homeopathic Pharmacopeia
By Eric Foxman, AAHP secretary February 1, 2018 A quick look at its history, purpose and contents, as well as the potential for adulteration and misbranding violations in the United…
Read MoreUnited States Food and Drug Administration – Good Guidance Practices
By Mark Land, AAHP president February 1, 2018 The Food and Drug Administration (FDA) amended its administrative regulations to codify its policies and procedures for the development, issuance, and use…
Read MoreProminence in Advertising and Labeling
By Mark Land, AAHP president February 1, 2018 A search under the term “prominence” yields 43 citations within Title 21 of the U.S. Code of Federal Regulations.1 Prominence appears 11…
Read MoreTesting the New AAHP Disclaimer for Effectiveness
By Jeremy Kees, PhD, Professor, Marketing & Business Law and Faculty Director, Villanova University February 1, 2018 The American Association of Homeopathic Pharmacists (AAHP) enlisted my assistance in 2017 to…
Read MoreAAHP Shares FDA’s Commitment to Protecting Public Health
December 19, 2017 In response to the U.S. Food and Drug Administration’s (FDA) draft guidance on homeopathic drug products released on Monday, December 18, 2017, the American Association of Homeopathic Pharmacists offers…
Read MoreArnica montana: A Clinical Snapshot
By Todd Hoover, MD December 11, 2017 Arnica montana has been used for centuries as a phytomedicine for its analgesic and anti-inflammatory properties. Commonly known as Wolf’s bane or Leopard’s…
Read More2017 Year in Review
2017 was a busy year for AAHP. With a new administration in the White House and key legislative issues heating up, the association had a full plate. But together with…
Read MoreSteps Toward Building Grassroots Support
December 6, 2017 Since the FDA hearing and the FTC workshop in 2015, the homeopathic industry has received more attention than usual from regulators. While AAHP continually meets with congressional…
Read MoreRecall Preparedness
By Mark Land, AAHP president November 20, 2017 Risks associated with the therapeutic use of healthcare products are real. Manufacturers and the U.S. Food and Drug Administration (FDA) balance these…
Read More